Loading...
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction.
Schimmel, Katharina Jung, Mira Foinquinos, Ariana José, Gorka San Beaumont, Javier Bock, Katharina Grote-Levi, Lea Xiao, Ke Bär, Christian Pfanne, Angelika
Schimmel, Katharina
Jung, Mira
Foinquinos, Ariana
José, Gorka San
Beaumont, Javier
Bock, Katharina
Grote-Levi, Lea
Xiao, Ke
Bär, Christian
Pfanne, Angelika
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-01-17
Submitted date
Files
Loading...
Open Access article
Adobe PDF, 3 MB
Other Titles
Abstract
High-throughput natural compound library screening identified 15 substances with antiproliferative effects in human cardiac fibroblasts. Using multiple in vitro fibrosis assays and stringent selection algorithms, we identified the steroid bufalin (from Chinese toad venom) and the alkaloid lycorine (from Amaryllidaceae species) to be effective antifibrotic molecules both in vitro and in vivo, leading to improvement in diastolic function in 2 hypertension-dependent rodent models of cardiac fibrosis. Administration at effective doses did not change plasma damage markers or the morphology of kidney and liver, providing the first toxicological safety data. Using next-generation sequencing, we identified the conserved microRNA 671-5p and downstream the antifibrotic selenoprotein P1 as common effectors of the antifibrotic compounds.
Citation
Circulation. 2020 Mar 3;141(9):751-767. doi: 10.1161/CIRCULATIONAHA.119.042559. Epub 2020 Jan 17.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
1524-4539
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International